Resistance Exercise to Improve Flu Vaccine for Older Adults
NCT03736759 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29
Last updated 2022-05-17
Summary
This study evaluates whether resistance exercise will improve immune responses to the seasonal influenza vaccine in older adults. One third of the participants will perform exercise in the arm that receives the vaccine, one third of the participants will perform the same exercise in the arm that does not receive the vaccine, and one third will only receive the vaccine.
Conditions
- Influenza, Human
Interventions
- BEHAVIORAL
-
Exercise
10 sets of 5 repetitions of 80% of calculated one-repetition maximum weight of lateral side arm raise and biceps curls, alternating
Sponsors & Collaborators
-
National Institute on Aging (NIA)
collaborator NIH -
University of Houston
lead OTHER
Principal Investigators
-
Emily C LaVoy, PhD · University of Houston
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-10-08
- Primary Completion
- 2019-04-30
- Completion
- 2021-04-01
Countries
- United States
Study Locations
More Related Trials
-
Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists
NCT01737580 ·Status: COMPLETED ·Phase: PHASE1
-
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
NCT04101838 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes
NCT03654937 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine
NCT01201902 ·Status: COMPLETED ·Phase: PHASE3
-
Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults
NCT00133471 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
H9 Priming Study in Healthy Adults
NCT00617331 ·Status: COMPLETED ·Phase: PHASE2
-
Flu and Mood in Older Adults
NCT03956329 ·Status: COMPLETED ·Phase: NA
-
Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults
NCT01701752 ·Status: COMPLETED ·Phase: PHASE1
-
A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD
NCT03734237 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Factors Associated With Maintenance of Antibody Responses to Influenza Vaccine in Older, Community-Dwelling Adults
NCT02401893 ·Status: COMPLETED
-
Th1 Response to Influenza: Aging and Vaccine Efficacy
NCT00396305 ·Status: TERMINATED ·Phase: PHASE4
-
Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population
NCT00318058 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Response Study of Influenza Vaccine
NCT01310374 ·Status: COMPLETED
-
Immune Response of Intradermal and Intramuscular Preparations of Inactive Seasonal Influenza Vaccine in Older Age Group.
NCT02101749 ·Status: COMPLETED ·Phase: PHASE4
-
Mood and Influenza Vaccine Response: A Feasibility Trial
NCT03144518 ·Status: COMPLETED ·Phase: NA
-
Open-Label Influenza Vaccine Evaluation
NCT02872311 ·Status: COMPLETED ·Phase: NA
-
Gene Signatures of Influenza Vaccine Responses in Older Adults
NCT03603509 ·Status: COMPLETED ·Phase: PHASE4
-
Studying Cell Immune Responses to a Live Flu Vaccine in Healthy Adults
NCT01730144 ·Status: COMPLETED
-
Comparison of Delivery Routes of Flu Vaccine in Adults
NCT00170547 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity Study of the Influenza Vaccine in Adults
NCT00258934 ·Status: COMPLETED ·Phase: PHASE2
-
The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination
NCT02876159 ·Status: COMPLETED ·Phase: PHASE4
-
Preventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccine
NCT03572491 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of Influenza Vaccine in Long Term Care
NCT02933723 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults
NCT05875961 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza
NCT00706732 ·Status: COMPLETED ·Phase: PHASE1/PHASE2